Lv1
50 积分 2025-07-16 加入
Chelerythrine Chloride is an Affinity-Labeling Inactivator of CYP3A4 by Modification of Cysteine239
2天前
已完结
Effects of Cytochrome P450 enzymes and drug–drug interaction on donafenib metabolism: in vivo, in vitro and in silico
4个月前
已完结
Effects of CYP3A4 variants and drug–drug interactions on the metabolism of fexinidazole
4个月前
已完结
Identification and Functional Assessment of Eight CYP3A4 Allelic Variants *39–*46 Detected in the Chinese Han Population
4个月前
已完结
Inhibitory effect of imperatorin on dabrafenib metabolism in vitro and in vivo
6个月前
已完结
Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
6个月前
已完结
The effect of Resveratrol on the pharmacokinetic profile of tofacitinib and the underlying mechanism
6个月前
已完结
Inhibitory effects of nimodipine, nitrendipine and felodipine on tamoxifen metabolism and molecular docking
6个月前
已完结
Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)
7个月前
已完结
Determination and pharmacokinetic study of riociguat by UPLC-MS/MS in human plasma
8个月前
已完结
皖公网安备34019202002308
